Trajan Wealth LLC Makes New Investment in The Cooper Companies, Inc. $COO

Trajan Wealth LLC bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 179,269 shares of the medical device company’s stock, valued at approximately $12,291,000. Trajan Wealth LLC owned about 0.09% of Cooper Companies at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in Cooper Companies by 1.8% during the second quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company’s stock valued at $1,725,963,000 after buying an additional 421,423 shares during the period. State Street Corp boosted its stake in Cooper Companies by 1.2% in the second quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock valued at $616,227,000 after acquiring an additional 104,910 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Cooper Companies by 2.5% during the 2nd quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company’s stock valued at $368,893,000 after acquiring an additional 127,907 shares during the period. Ameriprise Financial Inc. increased its stake in shares of Cooper Companies by 98.8% during the 2nd quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after purchasing an additional 1,683,561 shares during the last quarter. Finally, Sustainable Growth Advisers LP bought a new stake in shares of Cooper Companies in the 2nd quarter worth approximately $240,881,000. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

COO has been the topic of several research analyst reports. Piper Sandler reiterated an “overweight” rating and issued a $94.00 price objective (up previously from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. Mizuho set a $100.00 price objective on Cooper Companies and gave the stock an “outperform” rating in a report on Friday, December 5th. Morgan Stanley upped their price objective on shares of Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 8th. Finally, William Blair upgraded shares of Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $90.77.

Cooper Companies Stock Up 0.5%

COO opened at $84.07 on Monday. The firm has a market capitalization of $16.48 billion, a P/E ratio of 44.72, a price-to-earnings-growth ratio of 2.40 and a beta of 1.03. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $92.84. The company has a fifty day moving average price of $82.12 and a 200-day moving average price of $75.30. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The company had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter last year, the business posted $1.04 earnings per share. The firm’s revenue was up 4.6% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Albert G. White III bought 10,000 shares of the company’s stock in a transaction on Tuesday, December 16th. The stock was acquired at an average cost of $80.80 per share, for a total transaction of $808,000.00. Following the completion of the transaction, the chief executive officer directly owned 236,151 shares in the company, valued at $19,081,000.80. This trade represents a 4.42% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Holly R. Sheffield purchased 1,230 shares of the business’s stock in a transaction on Tuesday, December 16th. The stock was bought at an average cost of $80.75 per share, with a total value of $99,322.50. Following the purchase, the insider owned 39,052 shares in the company, valued at approximately $3,153,449. This represents a 3.25% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders have purchased 16,014 shares of company stock worth $1,304,416. Company insiders own 1.98% of the company’s stock.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.